Research programme: HIV fusion inhibitors - Frontier BiotechnologiesAlternative Names: Second generation HIV fusion inhibitors - Frontier Biotechnologies; Vaginal microbicide - Frontier Biotechnologies
Latest Information Update: 16 Jul 2016
At a glance
- Originator Frontier Biotechnologies
- Mechanism of Action HIV fusion inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in China (Vaginal)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in China
- 23 Sep 2011 Preclinical trials in HIV infections in China (Vaginal)